| 000 | 01563 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514020927.0 | ||
| 264 | 0 | _c20020122 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm010924c _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaraldi, Pier Giovanni | |
| 245 | 0 | 0 |
_a7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cJan 2002 |
||
| 300 |
_a115-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 | _aChromatography, Thin Layer |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aFurans _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPurinergic P1 Receptor Antagonists |
| 650 | 0 | 4 |
_aPyrimidines _xchemical synthesis |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 | _aReceptor, Adenosine A2A |
| 650 | 0 | 4 |
_aReceptors, Purinergic P1 _xmetabolism |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aCacciari, Barbara | |
| 700 | 1 | _aRomagnoli, Romeo | |
| 700 | 1 | _aSpalluto, Giampiero | |
| 700 | 1 | _aMonopoli, Angela | |
| 700 | 1 | _aOngini, Ennio | |
| 700 | 1 | _aVarani, Katia | |
| 700 | 1 | _aBorea, Pier Andrea | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 45 _gno. 1 _gp. 115-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm010924c _zAvailable from publisher's website |
| 999 |
_c11666999 _d11666999 |
||